Search results
Results from the WOW.Com Content Network
15–50% (with sudden stopping) [3] [4] Antidepressant discontinuation syndrome , also called antidepressant withdrawal syndrome , is a condition that can occur following the interruption, reduction, or discontinuation of antidepressant medication following its continuous use of at least a month. [ 5 ]
Online, people claim they get brain zaps after stopping use of drugs like Lexapro (escitalopram), Cymbalta (duloxetine), and Paxil (paroxetine), but they can happen when you stop taking any type ...
Escitalopram, a less recognizable term, is the generic name for this common prescription antidepressant. ... Never stop taking the medication or adjust your dosage without speaking to your ...
Withdrawal symptoms usually start within 5 days of stopping the medicine and last 1 to 2 weeks, and are typically mild, according to the NHS and American Academy of Family Physicians. However ...
Escitalopram, sold under the brand names Lexapro and Cipralex, among others, is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class. [9] It is mainly used to treat major depressive disorder , [ 9 ] generalized anxiety disorder , [ 9 ] panic disorder , obsessive-compulsive disorder , and social anxiety disorder .
Fluvoxamine, escitalopram, and citalopram were not well-tested for this disorder. MAOIs , while some of them may be helpful, are not used much because of their unwanted side effects. This leaves paroxetine and sertraline as acceptable treatment options for some people, although more effective antidepressants are needed.
Escitalopram (Lexapro) While many antidepressants can cause ED and other intimate dysfunction, some may be more likely than others. ... Abruptly stopping your medication can result in flu-like ...
The stopping of antidepressants for example, can lead to antidepressant discontinuation syndrome. With careful physician attention, however, medication prioritization and discontinuation can decrease costs, simplify prescription regimens, decrease risks of adverse drug events and poly-pharmacy, focus therapies where they are most effective, and ...